Mirum Pharmaceuticals, Inc.

Associate Director, Program Management

Mirum Pharmaceuticals, Inc.  •  $195k - $225k/yr  •  Foster City, CA (Hybrid)  •  1 month ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

MISSION

Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.

The Associate Director, Program Management plays a central role within Mirum by providing program management expertise and ensuring cross-functional planning and execution. The program manager partners with the Program Lead and functional leads to develop and manage the integrated product plan, develop timelines, and ensure adherence to the budget for one of our pipeline programs.

JOB FUNCTIONS/RESPONSIBILITIES

  • Support the Program Lead with the development, communication, and timely execution of the program strategy
  • Organize and drive effective and action-oriented program team meetings by preparing and distributing agendas/minutes, identifying and tracking decisions and action items to resolution, and escalating areas of concern as needed
  • Partner with the Program Lead to facilitate effective cross-functional decision making with transparent communication and clear escalation pathways
  • Facilitate identification of risks which could impact the program’s strategic goals; propose and implement plans to mitigate risks or develop contingencies
  • Develop and maintain integrated program timelines in conjunction with functional leads
  • Identify and communicate program priorities, interdependencies, and critical path activities to all stakeholders to allow long term planning, including resource allocation
  • Organize the preparation of high-quality documents for review by governance committees in collaboration with the Program Lead and program team
  • Prepares and provides project documents and information for monthly reports, executive team updates, and board meetings.
  • Partner with Program Lead and finance and accounting to develop annual operating plan components related to assigned program and support budget management by timely identification of out-of-scope activities
  • Coordinate and manage special program-related projects, as assigned
  • Contribute to the standardization of project management best practices at Mirum

QUALIFICATIONS

Education /Experience:

  • Bachelors Degree or higher in scientific/healthcare/business field
  • Experience (7+ years) in clinical research and project management within the pharmaceutical industry (Biotech/small pharma experience preferred).
  • Experience in rare disease and/or liver disease is a plus.

Knowledge, Skills and Abilities:

  • Strong ability to communicate effectively with team members creating an environment that fosters successful teamwork, collaboration and cooperation.
  • Thorough understanding of clinical trial management processes and the operation of all clinical development functional areas.
  • Demonstrated ability to prepare timelines and present related information to management.
  • Proven ability to identify risks, propose mitigation strategies, and remove barriers to success.
  • Strong attention to detail and the ability to work collaboratively with Project Lead to establish priorities for team.
  • Expertise in developing and managing project scope, deliverables, risks and resource requirements.
  • Strong knowledge of project management software packages and the Microsoft Office Suite: Excel, Project, PowerPoint, Word and Outlook; ability to create effective presentations for internal and external use.
  • Ability to work in a fast paced environment with demonstrated ability to juggle multiple competing tasks and demands, across time-zones, while maintaining positive attitude.
  • Ability to work independently, take initiative, complete tasks to deadlines and support product team in doing the same.
  • Excellent written and oral communication skills.
  • Displays a high level of professionalism with internal and external stakeholders.
  • Knowledge of current regulatory requirements and guidelines governing clinical research. (e.g. ICH/GCP).

The salary range for this position is $195,084 to $225,217 USD. Compensation will be determined based on several factors including, but not limited to; skill set, years of experience, and the employee’s geographic location. Please note that the required compensation details listed in US role postings reflect the base salary only, and do not include bonus, equity, or benefits unless otherwise provided.

#LI-HYBRID

Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.

Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.

Mirum Pharmaceuticals, Inc.

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat), CHOLBAM® (cholic acid) capsules, and CTEXLI™ (chenodiol) tablets.

LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients 12 months of age and older; in Europe, it is approved for patients with PFIC three months of age and older. Mirum is also initiating the Phase 3 EXPAND study, a label expansion opportunity for LIVMARLI in additional settings of cholestatic pruritus. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms of liver disease. CTEXLI is FDA-approved for the treatment of cerebrotendinous xanthomatosis (CTX) in adults.

Mirum's late-stage pipeline includes two investigational treatments for several rare diseases. Volixibat, an IBAT inhibitor, is being evaluated in two potentially registrational studies including the Phase 2 VISTAS study for primary sclerosing cholangitis (PSC) and Phase 2b VANTAGE study for primary biliary cholangitis (PBC). Volixibat has been granted Breakthrough Therapy Designation for the treatment of cholestatic pruritus in patients with PBC. Mirum is also planning for a Phase 2 study evaluating MRM-3379, a PDE4D inhibitor for the treatment of Fragile X syndrome, a rare genetic neurocognitive disorder.

Industry
Chemicals & Materials
Company Size
201-500 employees
Headquarters
Foster City, CA
Year Founded
2018
Social Media